ES495102A0 - Un procedimiento para la preparacion de un derivado de iminohalogenuro - Google Patents

Un procedimiento para la preparacion de un derivado de iminohalogenuro

Info

Publication number
ES495102A0
ES495102A0 ES495102A ES495102A ES495102A0 ES 495102 A0 ES495102 A0 ES 495102A0 ES 495102 A ES495102 A ES 495102A ES 495102 A ES495102 A ES 495102A ES 495102 A0 ES495102 A0 ES 495102A0
Authority
ES
Spain
Prior art keywords
iminohalogenide
derivative
procedure
preparation
iminohalogenide derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES495102A
Other languages
English (en)
Other versions
ES8106530A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21732838&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES495102(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES495102A0 publication Critical patent/ES495102A0/es
Publication of ES8106530A1 publication Critical patent/ES8106530A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10WGENERIC PACKAGES, INTERCONNECTIONS, CONNECTORS OR OTHER CONSTRUCTIONAL DETAILS OF DEVICES COVERED BY CLASS H10
    • H10W72/00Interconnections or connectors in packages
    • H10W72/071Connecting or disconnecting
    • H10W72/0711Apparatus therefor
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
ES495102A 1979-02-01 1980-09-16 Un procedimiento para la preparacion de un derivado de iminohalogenuro Expired ES8106530A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/008,647 US4226986A (en) 1979-02-01 1979-02-01 Process for halogenation of β-lactam compounds

Publications (2)

Publication Number Publication Date
ES495102A0 true ES495102A0 (es) 1981-08-16
ES8106530A1 ES8106530A1 (es) 1981-08-16

Family

ID=21732838

Family Applications (2)

Application Number Title Priority Date Filing Date
ES488234A Expired ES8104302A1 (es) 1979-02-01 1980-02-01 Un procedimiento para preparar un derivado de cefema
ES495102A Expired ES8106530A1 (es) 1979-02-01 1980-09-16 Un procedimiento para la preparacion de un derivado de iminohalogenuro

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES488234A Expired ES8104302A1 (es) 1979-02-01 1980-02-01 Un procedimiento para preparar un derivado de cefema

Country Status (22)

Country Link
US (1) US4226986A (es)
EP (1) EP0014566B1 (es)
JP (1) JPS55104289A (es)
KR (2) KR830001906B1 (es)
BE (1) BE881426A (es)
BG (1) BG35896A3 (es)
CA (1) CA1150725A (es)
CH (1) CH642971A5 (es)
CS (1) CS275604B6 (es)
DE (1) DE3063395D1 (es)
ES (2) ES8104302A1 (es)
FR (1) FR2447926A1 (es)
GB (1) GB2041374B (es)
HU (1) HU182065B (es)
IE (1) IE49503B1 (es)
IL (1) IL59266A (es)
IT (1) IT1130240B (es)
LU (1) LU82121A1 (es)
MX (1) MX6576E (es)
PH (2) PH14774A (es)
RO (1) RO84256B (es)
ZM (1) ZM1280A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1148938A (en) * 1979-05-08 1983-06-28 John R. Corfield Preparation of cephalosporins and intermediates employed therein
US4281117A (en) * 1980-09-04 1981-07-28 Eli Lilly And Company Process for 3-chloro cephalosporin nucleus
IN181695B (es) * 1992-08-10 1998-09-05 Ranbaxy Lab Ltd
US5604222A (en) * 1993-12-27 1997-02-18 Lupin Laboratories, Ltd. Method for the preparation of 2-chloro sulfinyl azetidinones
US5578721A (en) * 1994-07-11 1996-11-26 Lupin Laboratories Limited Process for preparation of 3-exomethylene cepham sulfoxide esters
JP6669831B2 (ja) * 2018-10-02 2020-03-18 株式会社ユニバーサルエンターテインメント 遊技機

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925372A (en) * 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
US3962227A (en) * 1973-02-23 1976-06-08 Eli Lilly And Company 3-halo cephalosporins
GB1472869A (en) * 1975-08-11 1977-05-11 Farmaceutici Italia Intermediates for cephalosporin synthesis
IE45158B1 (en) * 1976-08-16 1982-06-30 Lilly Co Eli 3-chloro-cephem synthesis
GB1576219A (en) * 1976-12-31 1980-10-01 Connlab Holdings Ltd Thiazoleneazetidinone derivatives

Also Published As

Publication number Publication date
FR2447926B1 (es) 1982-12-31
IT8019610A0 (it) 1980-01-31
BE881426A (fr) 1980-07-30
CS275604B6 (en) 1992-03-18
IT1130240B (it) 1986-06-11
IE800187L (en) 1980-08-01
US4226986A (en) 1980-10-07
HU182065B (en) 1983-12-28
CA1150725A (en) 1983-07-26
ES488234A0 (es) 1981-04-16
BG35896A3 (en) 1984-07-16
KR830001892B1 (ko) 1983-09-17
PH14774A (en) 1981-12-09
DE3063395D1 (en) 1983-07-07
FR2447926A1 (fr) 1980-08-29
RO84256B (ro) 1984-07-30
CH642971A5 (fr) 1984-05-15
KR830001906B1 (ko) 1983-09-19
EP0014566B1 (en) 1983-05-25
PH17758A (en) 1984-11-27
KR830001955A (ko) 1983-05-21
JPS55104289A (en) 1980-08-09
ES8104302A1 (es) 1981-04-16
MX6576E (es) 1985-07-24
GB2041374A (en) 1980-09-10
LU82121A1 (fr) 1980-04-23
RO84256A (ro) 1984-05-23
JPH0115515B2 (es) 1989-03-17
IL59266A (en) 1983-05-15
EP0014566A1 (en) 1980-08-20
ZM1280A1 (en) 1980-09-22
GB2041374B (en) 1983-04-13
CS8000660A2 (en) 1991-03-12
IL59266A0 (en) 1980-05-30
ES8106530A1 (es) 1981-08-16
KR830001957A (ko) 1983-05-19
IE49503B1 (en) 1985-10-16

Similar Documents

Publication Publication Date Title
ES493327A0 (es) Procedimiento para la obtencion de derivado de la difenilu- rea halogenosustituidos
ES505548A0 (es) Un procedimiento para la preparacion de nuevos derivados de diarilaminofluorano
AR222204A1 (es) Un procedimiento para la preparacion de derivados de i-bencilimidazol
ES497640A0 (es) Un procedimiento para la preparacion de derivados de la 7- amino-4-trifluormetilcumarina
ES489752A0 (es) Un procedimiento para la preparacion de un derivado de imi- dazolidindiona
ES501805A0 (es) Un procedimiento para la preparacion de derivados de la eta-nolamina
ES496798A0 (es) Un procedimiento para la preparacion de un derivado de aze- tidina
ES495892A0 (es) Un procedimiento para la preparacion de metacroleina
ES500385A0 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
ES490510A0 (es) Un procedimiento para la preparacion de derivados de penici-lina
ES489470A0 (es) Un procedimiento para la preparacion de 9-aminoalquilfluore-no
ES491370A0 (es) Un procedimiento para la preparacion de piridizinobenzodiazepinas
ES496487A0 (es) Un procedimiento para la preparacion de nuevos derivados hi-droxialquil-triazoles
ES505555A0 (es) Un procedimiento para la preparacion de derivados de imida- zol
ES490667A0 (es) Procedimiento para la preparacion de un derivado de 2-hidro-xi-5-(1-hidroxi-2-piperaciniletil)benzoico
ES495865A0 (es) Un procedimiento para la preparacion de derivados de quina- zolina
ES491992A0 (es) Un procedimiento para la preparacion de nuevos derivados de hidroxiamino-eburnano
ES490022A0 (es) Un procedimiento para la preparacion de imidazobenzodiacepi-nas
ES490289A0 (es) Un procedimiento para la preparacion de derivados de xantina
ES494091A0 (es) Un procedimiento para la preparacion de derivados de pirro- lidina
ES495102A0 (es) Un procedimiento para la preparacion de un derivado de iminohalogenuro
AR222208A1 (es) Un procedimiento para la preparacion de derivados de 4-amino-2-piperidino-quinazolina
ES491662A0 (es) Un procedimiento para la preparacion de un pirazol cuaterna-rio
ES489227A0 (es) Un procedimiento para la preparacion de un derivado de pira-zol
ES490287A0 (es) Un procedimiento para la preparacion de 2-aminopirazinas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010228